Physicochemical properties and antibacterial activity of the precipitate of vancomycin and ceftazidime: Implications in the management of endophthalmitis

Retina

Volumn 28, Issue 2, 2008, Pages 320-325

  Raju, Biju ^a   Bali, Tinku ^a   Thiagarajan, Geetha ^a   Rao, Venkateshwara ^a   Das, Taraprasad ^a   Sharma, Savitri ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

Bioavailability; Ceftazidime; Endophthalmitis; Precipitate; Vancomycin

Indexed keywords

CEFTAZIDIME; RINGER SOLUTION; TAZID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DETERMINATION; ENDOPHTHALMITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT SCATTERING; NONHUMAN; PH; PHYSICAL CHEMISTRY; BIOAVAILABILITY; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; ESCHERICHIA COLI; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; PRECIPITATION; SPECTROFLUOROMETRY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; CEFTAZIDIME; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; ENDOPHTHALMITIS; ESCHERICHIA COLI; HUMANS; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; PRECIPITATION; SPECTROMETRY, FLUORESCENCE; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 42449097774     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318154ba07     Document Type: Article

References (19)

1. Kattan HM, Flynn HW, Pflugfelder SC, et al. Nosocomial endophthalmitis survey: current incidence of infection after intraocular surgery. Ophthalmology 1991;98:227-238.
2. Das T, Dogra MR, Gopal L, et al. Postsurgical endophthalmitis: diagnosis & management. Ind J Ophthalmol 1995;43:103-116.
3. The Endophthalmitis Vitrectomy Study Group: Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postbacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-1496.
4. Campochiaro PA, Lim JI. Aminoglycoside toxicity in the treatment of endophthalmitis. The aminoglycoside toxicity study group. Arch Ophthalmol 1994;112:48-53.
5. Campochiaro PA, Conway BP. Aminoglycoside toxicity - a survey of retinal specialists. Arch Ophthalmol 1991;109:946-950.
6. Gallaway G, Ramsay A, Jordan K, et al. Macular infarction after intravitreal amikacin: mounting evidence against amikacin. Br J Ophthalmol 2002;86:359-360.
7. Lim JI, Campochiaro PA. Successful treatment of gramnegative endophthalmitis with intravitreous ceftazidime. Arch Ophthalmol 1992;110:1686.
8. Campochiaro PA, Green R. Toxicity of intravitreous ceftazidime in primate retina. Arch Ophthalmol 1992;110:1625-1629.
9. Lifshitz T, Lapid-Gortzak, Finkelman Y, et al. Vancomycin and ceftazidime incompatibility upon intravitreal injection. Br J Ophthalmol 2000;84:117-118.
10. Fischella RG. Physical incompatibility of vancomycin and ceftazidime for intravitreal injection. Arch Ophthalmol 1993;111:730.
11. Kwok AKH, Hut M, Pang CP, et al. An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: Implications for use in treating endophthalmitis. Invest Ophthalmol Vis Sci 2002;43:1182-1188.
12. Servais H, Tuklens P. Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients. Antimicrobial agents and chemotherapy 2001;45:2643-2647.
13. Raju B, Thiagarajan G, Das T. Modified high-performance liquid chromatography technique for detection of vancomycin in human vitreous. Ophthalmic Res 2004;36:55-61.
14. Kunimoto DY, Das T, Sharma S, et al. Microbiologic isolates and susceptibility of isolates: Part I. Postoperative Endophthalmitis. Am J Ophthalmol 1999;128:240-242.
15. Anand AR, Therese KL, Madhavan HN. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Ind J Ophthalmol 2000;48:123-128.
16. Hu MW, Anne L, Forni T, Gottwald K. Measurement of vancomycin in renally impaired patient's samples using a new high-performance liquid chromatography method with vit B12 internal standard. Comparison of high-performance liquid chromatography, EMIT and fluorescein polarization immunoassay. Ther Drug Monit 1990;12:562.
17. Benedek GB. Theory of transparency of the lens. Appl Opt 1971;10:459-473.
18. Thiagarajan G, Chandani S, Harinarayana Rao S, et al. Molecular and cellular assessment of ginkgo biloba extract as a possible ophthalmic drug. Exp Eye Res 2002;75:421-430.
19. Gan IM, van Dissel JT, Beekhuis WH, et al. Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis. Br J Ophthalmol 2001;85:1289-1293.